Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) just unveiled an update.
Alembic Pharmaceuticals Limited announced the successful completion of a United States Food and Drug Administration (USFDA) inspection at its API-III Facility in Karakhadi. The inspection, which took place from March 17 to March 21, 2025, concluded without any Form 483 observations, indicating compliance with Good Manufacturing Practices (GMP). This achievement is likely to bolster the company’s reputation in the pharmaceutical industry, ensuring continued trust from stakeholders and potentially enhancing its market position.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is a company in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical products. The company primarily deals with active pharmaceutical ingredients (APIs) and formulations, serving both domestic and international markets.
YTD Price Performance: -19.71%
Average Trading Volume: 5,427
Current Market Cap: 164.2B INR
See more insights into APLLTD stock on TipRanks’ Stock Analysis page.